Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Health authorities in Rio de Janeiro are reviewing samples from 288 donors after discovering that two HIV-positive people ...

New study confirms kidney transplants between HIV-positive individuals are safe expanding organ donation options and reducing ...

Study looked at 198 kidney transplants, found similar results whether donated organ came from person with or without AIDS ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

NBA Hall of Famer Earvin “Magic” Johnson is investing in a pharmacy startup that helps clinics with high volumes of HIV ...

Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck ( MRK -0 ...

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

FOLD and EDIT are in the spotlight following patent dispute settlement news and strategic updates, respectively.

High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...